Regulations/Legal

Latest Issue of OR Manager
January 2025
Home Regulations/Legal

Associations update guidelines on perioperative medication use for total joint patients

Editor's Note The American College of Rheumatology and the American Association of Hip and Knee Surgeons, on February 28, released a summary of their updated guideline for the “Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.” The guideline, which is…

Read More

By: Judy Mathias
March 1, 2022
Share

CDC issues new guidelines on masks

Editor's Note The Centers for Disease Control and Prevention (CDC), on February 25, issued new recommendations on when masks should be worn by the public. Under the new guidelines: In communities with “low” or “medium” levels of COVID-19, masks are not recommended for the general public, which is now more…

Read More

By: Judy Mathias
February 28, 2022
Share

Are HCWs abusing religious exemptions to avoid vaccinations?

Editor's Note According to a February 28 Politico article, titled “Want a COVID-19 vaccine exemption? It can be as easy as copy and paste,” hospital executives are starting to doubt the integrity of religious exemption requests, Becker’s Hospital Review reports. According to the Politico article, submitting a religious exemption is…

Read More

By: Tarsilla Moura
February 28, 2022
Share

FDA: Class I recall of Arrow International’s Arrow-Trerotola PTD

Editor's Note The Food and Drug Administration (FDA) on February 23 identified the recall by Arrow International (Reading, Pennsylvania), a subsidiary of Teleflex Inc, of its Arrow-Trerotola Percutaneous Thrombolytic Device (PTD) as Class I, the most serious. The recall was initiated because of the risk of tip damage during use…

Read More

By: Judy Mathias
February 24, 2022
Share

Sponsored Message

Study: COVID-19 linked with increased risk of diabetes in youths

Editor's Note According to a study in the Morbidity and Mortality Weekly Report, COVID-19 increases the risk of and may contribute to new-onset diabetes among children and adolescents, JAMA reports.  JAMA’s February 22 article notes that data from previous studies showed an average of 14% of adults hospitalized with COVID-19…

Read More

By: Tarsilla Moura
February 24, 2022
Share

FDA: Class I recall of Vyaire Medical’s Bellavista Ventilators

Editor's Note The Food and Drug Administration (FDA) on February 17 identified the recall by Vyaire Medical (Mettawa, Illinois) of its Bellavista 1000 and 1000e Series Ventilators as Class I, the most serious. The recall was initiated because of issues with the software version 6.0.1600.0 or higher, after reports of…

Read More

By: Judy Mathias
February 24, 2022
Share

Sponsored Message

CDC report: US maternal mortality rate higher in 2020

Editor's Note The Centers for Disease Control and Prevention (CDC) on February 23 released the “Maternal Mortality Rates in the United States” report for 2020, after analyzing data from the National Vital Statistics System and calculating mortality rates as the number of maternal deaths per 100,000 live births. The report…

Read More

By: Tarsilla Moura
February 24, 2022
Share

The Joint Commission releases 10 most common sentinel events of 2021

Editor's Note The Joint Commission recently released a Sentinel Event Data summary that includes a 2021 update and the 10 most common sentinel events reported to the accreditation body last year, the February 22 Becker’s Hospital Review reports. Only a small portion of all sentinel events are reported to The…

Read More

By: Tarsilla Moura
February 23, 2022
Share

FDA: Class I recall of BASE10 Genetics RNAstill MTM specimen collection kits

Editor's Note The Food and Drug Administration (FDA) on February 18 identified the recall by BASE10 Genetics of its RNAstill MTM specimen collection kits as Class I, the most serious. The specimen collection kits are intended for collection, transport, inactivation, stabilization, and long-term storage of nasopharyngeal or oropharyngeal swab samples…

Read More

By: Judy Mathias
February 23, 2022
Share

FDA: Class I recall of E25Bio COVID-19 Direct Antigen Rapid Tests

Editor's Note The Food and Drug Administration (FDA) on February 18 identified the recall by E25Bio (Cambridge, Massachusetts) of its COVID-19 Direct Antigen Rapid Tests as Class I, the most serious. The tests are being recalled for several reasons, particularly because they were marketed and distributed in the US without…

Read More

By: Judy Mathias
February 22, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat